Totals
- Total revenue
- $11,595,768
- Total expenses
- $12,586,852
- Contributions and grants received
- $10,084,711
- Grants paid
- $2,930,843
- Program service revenue
- $1,933,982
- Investment income
- $207,360
- Other revenue
- -$630,285
- Total assets, end of year
- $14,679,906
- Total liabilities, end of year
- $5,940,214
- Net assets or fund balances, end of year
- $8,739,692
- Program services expenses (Part IX)
- $9,692,145
- Management and general expenses
- $1,439,471
- Fundraising expenses
- $1,455,236
- Program service expenses (Part III)
- $9,692,145
Program services were 77.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1a · Federated campaigns
$174
-
1b · Membership dues
$30,933
-
1c · Fundraising events
$2,702,831
-
1e · Government grants (contributions)
$395,842
-
1f · All other contributions, gifts and grants
$6,954,931
-
1g · Noncash contributions included above
$25,559
-
2a · Program service revenue: ADVERTISING INCOME
total $1,016,015 · unrelated business $1,016,015
-
2b · Program service revenue: PRODUCT CERTIFICATION
total $484,392 · related or exempt $484,392
-
2c · Program service revenue: PATIENT RECRUITMENT
total $369,983 · related or exempt $369,983
-
2d · Program service revenue: ROYALTIES
total $38,299 · related or exempt $38,299
-
2e · Program service revenue: SCIENTIFIC ADVISORY
total $12,000 · related or exempt $12,000
-
2f · All other program service revenue
total $13,293 · related or exempt $13,293
-
3 · Investment income
total $318,103 · excluded $318,103
-
7a · Gross sales of assets other than inventory
securities $418,929
-
7b · Less cost or other basis and sales expenses
securities $529,672
-
7c · Gain or loss
securities -$110,743
-
7d · Net gain or loss
total -$110,743 · excluded -$110,743
-
8a · Fundraising events: gross income
$0
-
8a · Fundraising events: contributions included on line 1c
$2,702,831
-
8b · Fundraising events: direct expenses
$630,547
-
8c · Net income from fundraising events
total -$630,547 · excluded -$630,547
-
10a · Gross sales of inventory
$262
-
10b · Cost of goods sold
$0
-
10c · Net income from sales of inventory
total $262 · related or exempt $262
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $2,293,189 · program services $2,293,189
-
3 · Grants to foreign organizations and individuals
total $637,654 · program services $637,654
-
5 · Compensation of officers, directors and key employees
total $1,143,882 · program services $814,346 · management and general $209,199 · fundraising $120,337
-
7 · Other salaries and wages
total $4,250,383 · program services $3,025,907 · management and general $777,332 · fundraising $447,144
-
8 · Pension plan contributions
total $191,293 · program services $136,184 · management and general $34,985 · fundraising $20,124
-
9 · Other employee benefits
total $333,980 · program services $237,765 · management and general $61,080 · fundraising $35,135
-
10 · Payroll taxes
total $393,380 · program services $280,053 · management and general $71,943 · fundraising $41,384
-
11b · Fees: legal
total $48,101 · program services $32,709 · management and general $9,620 · fundraising $5,772
-
11c · Fees: accounting
total $18,605 · program services $12,651 · management and general $3,721 · fundraising $2,233
-
11d · Fees: lobbying
total $245,323 · program services $245,323
-
11e · Fees: professional fundraising services
total $233,613 · fundraising $233,613
-
11f · Fees: investment management
total $31,857 · management and general $31,857
-
11g · Fees: other
total $407,613 · program services $373,998 · management and general $20,422 · fundraising $13,193
-
12 · Advertising and promotion
total $278,941 · program services $267,836 · fundraising $11,105
-
13 · Office expenses
total $67,711 · program services $34,320 · management and general $6,921 · fundraising $26,470
-
16 · Occupancy
total $155,087 · program services $110,409 · management and general $28,363 · fundraising $16,315
-
19 · Conferences, conventions and meetings
total $918,956 · program services $691,360 · management and general $11,519 · fundraising $216,077
-
22 · Depreciation, depletion and amortization
total $50,214 · program services $35,748 · management and general $9,183 · fundraising $5,283
-
23 · Insurance
total $57,871 · program services $41,199 · management and general $10,584 · fundraising $6,088
-
24a · Other expenses: DUES AND SUBSCRIPTIONS
total $363,879 · program services $271,326 · management and general $25,987 · fundraising $66,566
-
24b · Other expenses: PRINTING AND POSTAGE
total $205,310 · program services $93,176 · management and general $2,181 · fundraising $109,953
-
24c · Other expenses: TAXES
total $92,486 · management and general $92,486
-
24d · Other expenses: BANK FEES
total $76,714 · management and general $20,293 · fundraising $56,421
-
24e · All other expenses
total $90,810 · program services $56,992 · management and general $11,795 · fundraising $22,023
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $2,155,746 · end of year $1,023,562
-
3 · Pledges and grants receivable
beginning of year $1,788,781 · end of year $2,461,795
-
4 · Accounts receivable
beginning of year $703,034 · end of year $443,481
-
8 · Inventories for sale or use
beginning of year $4,370 · end of year $2,630
-
9 · Prepaid expenses and deferred charges
beginning of year $152,539 · end of year $226,382
-
10a · Land, buildings and equipment: cost or other basis
$474,439
-
10b · Land, buildings and equipment: accumulated depreciation
$250,562
-
10c · Land, buildings and equipment, net
beginning of year $385,368 · end of year $223,877
-
11 · Investments: publicly traded securities
beginning of year $8,511,304 · end of year $9,620,108
-
15 · Other assets
beginning of year $115,884 · end of year $678,071
-
17 · Accounts payable and accrued expenses
beginning of year $617,899 · end of year $952,666
-
18 · Grants payable
beginning of year $3,845,657 · end of year $4,024,290
-
19 · Deferred revenue
beginning of year $168,500 · end of year $121,375
-
25 · Other liabilities
beginning of year $166,320 · end of year $841,883
-
27 · Net assets without donor restrictions
beginning of year $5,506,333 · end of year $5,271,417
-
28 · Net assets with donor restrictions
beginning of year $3,512,317 · end of year $3,468,275
Mission and programs · 2023
Mission
THE NATIONAL PSORIASIS FOUNDATION PROVIDES PEOPLE WITH PSORIASIS AND PSORIATIC ARTHRITIS THE SERVICES THEY NEED TO BEST MANAGE THEIR CONDITION, WHILE PROMOTING RESEARCH TO FIND A CURE.
Activities or mission (Part I)
TO DRIVE EFFORTS TO CURE PSORIATIC DISEASE AND IMPROVE THE LIVES OF THOSE AFFECTED.
-
RESEARCHNPF CONTINUED TO LEAD COLLABORATIVE, TRANSFORMATIONAL RESEARCH BY ENSURING THAT FUNDING EXTRAMURAL RESEARCH REMAINED A PRIORITY. IN FY 2024, NPF INVESTED OVER $2.9M IN RESEARCH GRANTS AND FELLOWSHIP AWARDS. INTRODUCED IN 2020, THE NPF HAS INVESTED OVER $4M TOWARDS THE PSORIASIS PREVENTION INITIATIVE GRANT, A STUDY AIMED AT PREVENTING THE ONSET ON CARDIOVASCULAR DISEASE IN PEOPLE WITH PSORIATIC DISEASE, AND TO PROVIDE, TIMELY, ADEQUATE TREATMENT FOR THOSE DEEMED TO BE AT HIGH RISK OF DEVELOPING CARDIOVASCULAR DISEASE. IN FY 2023, THE PILOT PHASE OF THE UNIVERSITY OF PENNSYLVANIA-LED STUDY ON CVD CONCLUDED AND PLANNING BEGAN FOR THE LAUNCH OF THE FULL STUDY. THIS UNIQUE, SCALABLE MODEL THAT TESTS CARE COORDINATION ACROSS DERMATOLOGISTS AND PRIMARY CARE PROVIDERS SAW PROMISING EARLY RESULTS IN THE PILOT STUDY. OF THE 25% OF PEOPLE IN PHASE ONE WHO WERE IDENTIFIED AS HAVING AS HIGH RISK FOR CARDIOVASCULAR DISEASE, 85% FOLLOWED THROUGH WITH AN APPOINTMENT WITH THEIR HEALTH CARE PROVIDER TO ADDRESS CARDIOVASCULAR DISEASE. THE PSA DIAGNOSTIC TEST GRANT WAS LAUNCHED IN 2020 WITH THE GOAL OF ADVANCING THE DEVELOPMENT OF THE FIRST DIAGNOSTIC TEST FOR PSA, REDUCING GUESSWORK AND LONG DELAYS IN DIAGNOSIS AND TREATMENT. AT THE CONCLUSION OF THE STUDY THIS FISCAL YEAR, KEY FINDINGS OF THE RESEARCH EVIDENCING THE CRITICAL ADVANCEMENTS IN UNDERSTANDING THE DISEASE TO HELP INFORM THE WORK OF OTHER RESEARCHERS AND CLINICIANS WERE PUBLISHED IN SCIENCE IMMUNOLOGY. THE NPF CONTINUED TO COLLABORATE WITH PUBLIC-PRIVATE PARTNERS IN THE ACCELERATED MEDICINES PARTNERSHIP FOR AUTOIMMUNE AND IMMUNE-MEDIATED DISEASES INITIATIVE, PUBLISHED SEVERAL ABSTRACTS AND PAPERS, AND BROUGHT THE INTERNALLY GENERATED DATA TO THE COMMUNITY.
Expenses $3,846,872 · Grants $2,930,843
-
PROFESSIONAL EDUCATIONNPF CONTINUED TO EXPAND AND STRENGTHEN MEDICAL EDUCATION PROGRAMMING TARGETING HEALTH CARE PROVIDERS AT ALL LEVELS AND STAGES OF CAREER. THE 25TH ANNUAL NPF RESIDENTS' MEETING OFFERED DERMATOLOGY RESIDENTS THE LATEST IN PSORIATIC DISEASE TREATMENT PRESENTED BY EXPERTS IN THE FIELD. NPF ALSO LAUNCHED A COMPLIMENTARY RHEUMATOLOGY FELLOWS MEETING TO OFFER EDUCATION TO NEXT GENERATION RHEUMATOLOGISTS AND DEVELOP THE RELATIONSHIPS BETWEEN THESE FUTURE CARE COLLABORATORS. THE NPF HOSTED ITS BI-ANNUAL NPF RESEARCH SYMPOSIUM: A CURE FOR ALL, THE NATION'S PREMIER PSORIATIC DISEASE RESEARCH EVENT WHICH FEATURED SPEAKERS ON A WIDE ARRAY OF CURRENT TOPICS FROM THE PSORIASIS TO PSA TRANSITION TO THE RESULTS OF A NOVEL KNOCKOUT STUDY AIMING TO CLEAR PSORIASIS SYMPTOMS WITH EARLY AGGRESSIVE BIOLOGIC TREATMENT.THROUGH ITS DEDICATION TO EDUCATING HEALTH CARE PROVIDERS ON PSORIATIC DISEASE AND ITS RELATED DISEASES, NPF HAS EARNED ACCREDITATION AS A PROVIDER OF CONTINUING MEDICAL EDUCATION. IT'S PART OF OUR EFFORTS TO ENSURE ALL DIFFERENT TYPES OF HEALTH CARE PROVIDERS UNDERSTAND THIS COMPLICATED DISEASE. NPF OFFERS THE PSOUND BYTES CONTINUING MEDICAL EDUCATION PODCASTS, WEBINARS, AND IN-PERSON CLASSES AND SEMINARS FOR A WIDE RANGE OF AUDIENCES AND PUBLISHES THE JOURNAL OF PSORIASIS AND PSORIATIC ARTHRITIS, A PEER REVIEWED OUTLET FEATURING CME ARTICLES.
Expenses $1,321,080 · Revenue $12,000
-
ADVOCACYNPF CONTINUED TO ADVOCATE ON BOTH STEP THERAPY AND COPAY ACCUMULATOR ADJUSTMENT PROGRAMS TO ENSURE PATIENTS HAVE AFFORDABLE ACCESS TO THERAPIES. NPF ALSO LEVERAGED THOUSANDS OF ADVOCATES TO WORK FOR HEALTH INSURANCE COVERAGE IMPROVEMENTS FOR THE MILLIONS OF PEOPLE LIVING WITH PSORIATIC DISEASE, WHILE ALSO WORKING TO IMPROVE THE SAFETY AND AFFORDABILITY OF PSORIASIS AND PSA TREATMENTS AND INCREASING FEDERAL SUPPORT FOR PSORIATIC DISEASE RESEARCH.
Expenses $1,063,418
-
EDUCATION, OUTREACH, AND PATIENT SERVICESTHE NPF IS PROUD TO HAVE PUBLISHED THE FIRST EVER PSORIASIS HEALTH INDICATOR REPORT. THIS SET OF DATA ABOUT PSORIATIC DISEASE AND ITS IMPACTS WAS MADE POSSIBLE BY A PARTNERSHIP WITH THE CENTERS FOR DISEASE CONTROL AND THROUGH THE CONTRIBUTIONS OF TODAY'S LEADERS IN DERMATOLOGY AND RHEUMATOLOGY RESEARCH AND CLINICAL CARE. THE PSORIASIS HEALTH INDICATOR REPORT PROVIDES INFORMATION NEEDED TO EDUCATE THE GENERAL PUBLIC, HEALTH OFFICIALS, AND HEALTH CARE PROVIDERS ABOUT KEY ISSUES AND CHALLENGES AFFECTING THE MORE THAN 8 MILLION PEOPLE IN THE U.S. WHO LIVE WITH THIS DISEASE. SINCE 2016, NPF'S PATIENT NAVIGATION CENTER HAS SUPPORTED OVER 90,000 PATIENTS AND THEIR CAREGIVERS WITH FREE, PERSONALIZED SUPPORT DESIGNED TO HELP THEM UNDERSTAND PSORIATIC DISEASE AND TREATMENT OPTIONS, NAVIGATE INSURANCE CHALLENGES, AND FIND THE APPROPRIATE HEALTH CARE PROVIDER. NPF ADVANCE MAGAZINE CONTINUED TO PROVIDE THE LATEST INFORMATION, STORIES, AND RESOURCES FIVE TIMES ANNUALLY FOR OVER 25,000 PRINT SUBSCRIBERS AND HUNDREDS OF THOUSANDS OF ONLINE READERS. EACH WEEK, MORE THAN 283,000 PEOPLE RECEIVED ADVANCE WEEKLY, THE OFFICIAL PATIENT-FOCUSED E-NEWSLETTER OF NPF.
Expenses $3,460,775 · Revenue $906,229
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Leah McCormick HowardLEAH MCCORMICK HOWARD
PRESIDENT/CEO
- Total calculated
- $339,959
- From this org
- $304,524
- From related orgs
- $0
- Other
- $35,435
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $304,524
- Bonus
- $0
- Other
- $0
- Deferred
- $32,715
- Nontaxable benefits
- $2,720
- Filer's total
- $339,959
-
Randy Beranek Thru Dec 2021RANDY BERANEK THRU DEC 2021
FORMER PRESIDENT/CEO
- Total calculated
- $53,802
- From this org
- $53,802
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $0
- Bonus
- $0
- Other
- $53,802
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $53,802
-
Ronald GoldsmanRONALD GOLDSMAN
CHIEF FINANCIAL OFFICER
- Total calculated
- $232,904
- From this org
- $214,283
- From related orgs
- $0
- Other
- $18,621
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $214,283
- Bonus
- $0
- Other
- $0
- Deferred
- $17,024
- Nontaxable benefits
- $1,597
- Filer's total
- $232,904
-
Jennifer FagerstromJENNIFER FAGERSTROM
CHIEF REVENUE OFFICER
- Total calculated
- $267,276
- From this org
- $227,737
- From related orgs
- $0
- Other
- $39,539
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $227,737
- Bonus
- $0
- Other
- $0
- Deferred
- $24,254
- Nontaxable benefits
- $15,285
- Filer's total
- $267,276
-
Guy EakinGUY EAKIN
CHIEF SCIENTIFIC & MEDICAL OFFICER
- Total calculated
- $165,816
- From this org
- $153,257
- From related orgs
- $0
- Other
- $12,559
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $153,257
- Bonus
- $0
- Other
- $0
- Deferred
- $6,563
- Nontaxable benefits
- $5,996
- Filer's total
- $165,816
-
Rene IslasRENE ISLAS
CHIEF OF STAFF
- Total calculated
- $167,261
- From this org
- $140,595
- From related orgs
- $0
- Other
- $26,666
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $105,042
- Bonus
- $0
- Other
- $35,553
- Deferred
- $7,552
- Nontaxable benefits
- $19,114
- Filer's total
- $167,261
-
Jason HarrisJASON HARRIS
VICE PRESIDENT OF GOVERNMENT RELATIONS & ADVOCACY
- Total calculated
- $171,658
- From this org
- $153,312
- From related orgs
- $0
- Other
- $18,346
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $153,312
- Bonus
- $0
- Other
- $0
- Deferred
- $8,882
- Nontaxable benefits
- $9,464
- Filer's total
- $171,658
-
Katherine SouthwickKATHERINE SOUTHWICK
VICE PRESIDENT OF MARKETING & COMMUNICATIONS
- Total calculated
- $152,494
- From this org
- $136,394
- From related orgs
- $0
- Other
- $16,100
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $136,394
- Bonus
- $0
- Other
- $0
- Deferred
- $6,789
- Nontaxable benefits
- $9,311
- Filer's total
- $152,494
-
Breanna BaerBREANNA BAER
VICE PRESIDENT, FIELD DEVELOPMENT & OPERATIONS
- Total calculated
- $163,489
- From this org
- $141,302
- From related orgs
- $0
- Other
- $22,187
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $141,302
- Bonus
- $0
- Other
- $0
- Deferred
- $7,450
- Nontaxable benefits
- $14,737
- Filer's total
- $163,489
-
Robert FrieselROBERT FRIESEL
DIRECTOR OF RESEARCH & MEDICAL AFFAIRS
- Total calculated
- $146,601
- From this org
- $125,719
- From related orgs
- $0
- Other
- $20,882
- Hours/week
- 40
-
Carol OstrowCAROL OSTROW
CHAIR-ELECT
- Total calculated
- $0
- Hours/week
- 1
-
Eyal OfirEYAL OFIR
VICE CHAIR
- Total calculated
- $0
- Hours/week
- 1
-
Mike RefermatMIKE REFERMAT
TREASURER
- Total calculated
- $0
- Hours/week
- 1
-
Richard SeidenRICHARD SEIDEN
SECRETARY
- Total calculated
- $0
- Hours/week
- 1
-
Ron GrauRON GRAU
PAST CHAIR
- Total calculated
- $0
- Hours/week
- 1
-
Jonathan ScottJONATHAN SCOTT
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Larry Green MDLARRY GREEN MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Mary CarrollMARY CARROLL
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Michael GraffMICHAEL GRAFF
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Mark ObermanMARK OBERMAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Jason Lichten MDJASON LICHTEN MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Pete Miller Thru March 2023PETE MILLER THRU MARCH 2023
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Matthew T KiselicaMATTHEW T KISELICA
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
April Armstrong MD Thru June 2023APRIL ARMSTRONG MD THRU JUNE 2023
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Elaine Husni MDELAINE HUSNI MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Valerie Harrison From June 2023VALERIE HARRISON FROM JUNE 2023
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Diana Sandler From June 2023DIANA SANDLER FROM JUNE 2023
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Brian Janssen From June 2023BRIAN JANSSEN FROM JUNE 2023
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
Answered no
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- PART I, LINES 4A-B
- RANDY BERANAK RECEIVED A FINAL COMPENSATION PAYMENT OF $53,802 THAT WAS PAID OUT OVER TIME. EMPLOYER CONTRIBUTIONS TO 457(F): LEAH MCCORMICK HOWARD - $17,500 JENNIFER FAGERSTROM - $12,500 RONALD GOLDSMAN - $10,000
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
$1,111,190
PPI AWARD
-
$200,000
TRANSLATIONAL RESEARCH AWARD
-
TRANSLATIONAL RESEARCH AWARD
-
$100,000
BRIDGE GRANT
-
VANDERBILT UNIVERSITY MEDICAL CENTER
$100,000
BRIDGE GRANT
-
AMP AIM GRANT
-
DISCOVERY GRANT AWARD
-
DISCOVERY GRANT AWARD
-
DISCOVERY GRANT AWARD
-
DISCOVERY GRANT AWARD
The 10 largest by cash amount. The API serves every itemized grant.
Fundraising and gaming
From Schedule G of this return, as filed.
- Raised funds through (line 1)
- mail, email, phone, in person, non-government grants, special fundraising events
- Had an agreement with a professional fundraiser (line 2a)
- Yes
- Registered or licensed to solicit in (line 3)
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY
Professional fundraisers (line 2b)
Their names and addresses are not shown.
| Activity | Custody of contributions | Gross receipts | Kept by fundraiser | To the organization |
|---|---|---|---|---|
| DIRECT MAIL | No | $403,454 | $233,613 | $169,841 |
| Total, as filed | $403,454 | $233,613 | $169,841 | |
Fundraising events (Part II)
Part II has at most four columns: the two largest events, the rest together, and the total.
| Line | Event 1 PEER TO PEER (TAKE ACTION/TEAM NPF) | Event 2 COMMIT TO CURE GALA | Other events 1 events | Total |
|---|---|---|---|---|
| Gross receipts (line 1) | $905,365 | $777,887 | $1,019,579 | $2,702,831 |
| Less contributions (line 2) | $905,365 | $777,887 | $1,019,579 | $2,702,831 |
| Gross income (line 3) | — | — | — | — |
| Cash prizes (line 4) | — | — | — | — |
| Noncash prizes (line 5) | $11,505 | $5,837 | $6,634 | $23,976 |
| Rent and facility costs (line 6) | $14,926 | $28,577 | $155,038 | $198,541 |
| Food and beverages (line 7) | $7,773 | $14,883 | $80,742 | $103,398 |
| Entertainment (line 8) | $13,209 | $16,551 | $41,586 | $71,346 |
| Other direct expenses (line 9) | $56,584 | $72,110 | $104,592 | $233,286 |
- Direct expenses (line 10)
- $630,547
- Net income (line 11)
- -$630,547
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- 0
- Employees, agents and contractors (line 3c)
- 0
- Expenditures and investments (line 3c)
- $637,654
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Activities by region (Part I)
| Region | Offices | Employees | Activity | Specific services | Expenditures |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | GRANT EXPENSES | DISCOVERY AND EARLY CAREER RESEARCH GRANT | $89,000 |
| NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES | 0 | 0 | GRANT EXPENSES | PSA DIAGNOSTIC AWARD | $423,654 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | GRANT EXPENSE | EARLY CAREER RESEARCH GRANT | $50,000 |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | DISCOVERY GRANT | DISCOVERY GRANT | $75,000 |
Grants to organizations, by region (Part II)
The purpose of each grant is not shown.
| Region | Cash grants | Manner of disbursement | Noncash assistance | Noncash description | Valuation |
|---|---|---|---|---|---|
| MIDDLE EAST AND NORTH AFRICA | $75,000 | BANK DRAFT | $0 | — | — |
| EUROPE (INCLUDING ICELAND & GREENLAND) | $72,000 | BANK DRAFT | $0 | — | — |
| EUROPE (INCLUDING ICELAND & GREENLAND) | $17,000 | BANK DRAFT | $0 | — | — |
| NORTH AMERICA (CANADA AND MEXICO, BUT NOT U.S.) | $199,510 | BANK DRAFT | $0 | — | — |
| NORTH AMERICA (CANADA AND MEXICO, BUT NOT U.S.) | $50,000 | BANK DRAFT | $0 | — | — |
| NORTH AMERICA (CANADA AND MEXICO, BUT NOT U.S.) | $50,000 | BANK DRAFT | $0 | — | — |
| NORTH AMERICA (CANADA AND MEXICO, BUT NOT U.S.) | $49,710 | BANK DRAFT | $0 | — | — |
| NORTH AMERICA (CANADA AND MEXICO, BUT NOT U.S.) | $74,434 | BANK DRAFT | $0 | — | — |
| EAST ASIA AND THE PACIFIC | $50,000 | BANK DRAFT | $0 | — | — |
- Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
- 0
- Other grantees (Part II line 3)
- 9
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- No
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 30 January 2025
- IRS schema version
- 2023v6.0
- Source object
- 202530319349300033
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.